Lactobacillus johnsonii LJO02 (DSM 33828) Cell-Free Supernatant and Vitamin D Improve Wound Healing and Reduce Interleukin-6 Production in Staphylococcus aureus -Infected Human Keratinocytes.

MLA

Zanetta, Paola, et al. “Lactobacillus Johnsonii LJO02 (DSM 33828) Cell-Free Supernatant and Vitamin D Improve Wound Healing and Reduce Interleukin-6 Production in Staphylococcus Aureus -Infected Human Keratinocytes.” Pharmaceutics, vol. 16, no. 1, Jan. 2024, p. 18. EBSCOhost, https://doi.org/10.3390/pharmaceutics16010018.

APA

Zanetta, P., Ballacchino, C., Squarzanti, D. F., Amoruso, A., Pane, M., & Azzimonti, B. (2024). Lactobacillus johnsonii LJO02 (DSM 33828) Cell-Free Supernatant and Vitamin D Improve Wound Healing and Reduce Interleukin-6 Production in Staphylococcus aureus -Infected Human Keratinocytes. Pharmaceutics, 16(1), 18. https://doi.org/10.3390/pharmaceutics16010018

Chicago

Zanetta, Paola, Chiara Ballacchino, Diletta Francesca Squarzanti, Angela Amoruso, Marco Pane, and Barbara Azzimonti. 2024. “Lactobacillus Johnsonii LJO02 (DSM 33828) Cell-Free Supernatant and Vitamin D Improve Wound Healing and Reduce Interleukin-6 Production in Staphylococcus Aureus -Infected Human Keratinocytes.” Pharmaceutics 16 (1): 18. doi:10.3390/pharmaceutics16010018.